AXP vs INBS · P/E 20, rev $21.73B vs rev $4.2M
American Express Company (AXP) versus Intelligent Bio Solutions Inc. (INBS) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Intelligent Bio Solutions Inc. (INBS) is a medical devices company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported INBS revenue for 2026-06-30 was $4.2M. Net income was -$12.4M. Revenue was up 38.1% from 2025-06-30 to 2026-06-30. INBS currently screens at market cap $5.9M.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. INBS currently screens at market cap $5.9M.
Not investment advice. Open the AXP and INBS stock pages for the full models.
Not investment advice.